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Purpose. The study was conducted to investigate the impact of charge and molecular weight (MW) on
the iontophoretic delivery of a series of dipeptides.
Methods. Constant current iontophoresis of lysine and 10 variously charged lysine- and tyrosine-
containing dipeptides was performed in vitro.
Results. Increasing MW was compensated by additional charge; for example, Lys (MW = 147 Da, +1)
and H-Lys-Lys-OH (MW = 275 Da, +2) had equivalent steady-state fluxes of 225 T 48 and 218 T 40 nmol
cmj2 hj1, respectively. For peptides with similar MW, e.g., H-Tyr-D-Arg-OH (MW = 337 Da, +1) and
H-Tyr-D-Arg-NH2 (MW = 336 Da, +2), the higher valence ion displayed greater flux (150 T 26 vs. 237 T
35 nmol cmj2 hj1). Hydrolysis of dipeptides with unblocked N-terminal residues, after passage through
the stratum corneum, suggested the involvement of aminopeptidases. The iontophoretic flux of
zwitterionic dipeptides was less than that of acetaminophen and dependent on pH.
Conclusions. For the series of dipeptides studied, flux is linearly correlated to the charge/MW ratio.
Data for zwitterionic peptides indicate that they do not behave as neutral (Bcharge-less^) molecules, but
that their iontophoretic transport is dependent on the relative extents of ionization of the constituent
ionizable groups, which may also be affected by neighboring amino acids.
KEY WORDS: charge/molecular weight ratio; iontophoresis; peptide; skin metabolism; zwitterion.
INTRODUCTION
The poor oral bioavailability of peptides and proteins,
and the problems associated with their parenteral delivery
(e.g., patient compliance and risk of infection) have led to
continued interest in noninvasive delivery techniques. Trans-
dermal iontophoresis is a century-old technique that uses a
mild electric current to drive charged and uncharged mole-
cules across the skin. Peptides, which are usually charged at
physiological pH, are poor candidates for passive transdermal
delivery, but are very well suited for iontophoresis. As ion-
tophoresis also enables tight control over the drug adminis-
tration kinetics, it is especially useful for the delivery of
peptides that exhibit input rate-dependent pharmacological
activity (1,2).
Despite the growing interest in the iontophoretic delivery
of therapeutic peptides, and significant developments in the
Bapplied^ aspects of this mode of delivery, mechanistic dataV
especially those pertaining to peptide structureYpermeation
relationshipsVhave not been forthcoming. Fundamental
issues concerning the relative importance of physicochemical
characteristics, which may ultimately allow the delivery
efficiency of a given peptide to be estimated (if not predicted),
remain elusive. Clearly, formulation optimization in the
absence of such data can only proceed in an empirical and
time-consuming fashion.
The work presented in this paper represents a systematic
study of the factors governing transdermal iontophoretic
peptide delivery, in particular, the dependence of iontopho-
retic transport on peptide charge and molecular weight (MW).
The main objectives were: (1) to determine whether increas-
ing peptide charge could compensate increasing MW, (2) to
evaluate the impact of increasing charge in a peptide of given
MW, and (3) to investigate zwitterion iontophoresis and the
effect of partial charge on transport. The effect of metabolism
on peptide transport, particularly with respect to the role of
peptide structure in determining hydrolytic susceptibility,
and the site of enzymatic degradation in the skin, was also
investigated. Two series of dipeptides were selected for this
study: the first was a group of unblocked lysine-containing
dipeptides, the second a series of (unblocked and partially
blocked) tyrosine-containing dipeptides. These peptides have
low MW (õ300 Da) and differ from each other with respect
to their ionization state at the pH of the experiment.
Coiontophoresis of acetaminophen was used to determine
the respective contributions of electromigration (EM) and
electroosmosis (EO) to peptide transport.
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MATERIALS AND METHODS
Materials
Lysine, tyrosine, citric acid, and acetonitrile (Acetonitrile
Chromasolv\ for HPLC, gradient grade) were purchased
from Sigma-Aldrich (Saint Quentin Fallavier, France). The
dipeptides H-Lys-Lys-OH, H-His-Lys-OH, H-Glu-(-Lys-OH,
H-Tyr-D-Arg-OH, H-Tyr-Lys-NH2, H-Tyr-His-OH, H-Tyr-
Gln-OH, H-Tyr-Phe-NH2, and Ac-Tyr-Phe-OH were
obtained from Bachem (Voisins-le-Bretonneux, France).
The dipeptide H-Tyr-D-Arg-NH2 was custom-synthesized by
NeoMPS (Strasbourg, France). Acetaminophen, sodium
hydrogen carbonate, sodium chloride, disodium hydrogen
phosphate, potassium dihydrogen phosphate, dabsyl chloride,
and trifluoroacetic acid (TFA) were purchased from Fluka
(Saint Quentin Fallavier, France). All solutions were pre-
pared using deionized water (resistivity > 18 MW cm).
Porcine ears were obtained fresh from a local abattoir
(Socie´te´ d’Exploitation d’Abbatage, Annecy, France). The
excised skin was then dermatomed (õ750 mm) on the same
day and stored at j20-C for a maximum period of 2 months.
Iontophoresis Setup
The experiments were performed using vertical ionto-
phoretic cells as described by Glikfeld et al. (3). These cells,
in contrast to side-by-side cells, permit both electrodes to be
applied to the external side of the skin [stratum corneum
(SC)], thus simulating in vivo conditions. A flow-through sys-
tem was used to sample the receiver compartment (flow rate:
3 mL hj1) hourly in the studies with lysine, H-Lys-Lys-OH,
H-His-Lys-OH, H-Glu-(-Lys-OH, H-Tyr-D-Arg-OH, H-Tyr-
D-Arg-NH2, and Ac-Tyr-Phe-OH. In the case of H-Tyr-Lys-
NH2, H-Tyr-His-OH, H-Tyr-Gln-OH, and H-Tyr-Phe-NH2,
the receiver compartment was replaced manually every hour.
A current of 0.34 mA (corresponding to a current density of
0.5 mA cmj2) was applied for 5 h in the case of lysine and
lysine-containing dipeptides, and 7 h for tyrosine dipeptides.
This current was generated by a power supply (Kepco,
Flushing, NY, USA, or Iomed, Salt Lake City, UT, USA).
Silver and silver chloride electrodes were used as the anode
and cathode, respectively. The receiver volume was õ4.7 mL.
After equilibration of each compartment for 1 h with the buffer
(see below), 1 mL of a buffered solution of each peptide was
introduced into the appropriate donor compartment.
Acetaminophen (15 mM) was added to the donor solution
as a marker for EO flow: as a polar but uncharged molecule, it
is transported by EO during transdermal iontophoresis, its
passive delivery being negligible. The latter was confirmed in
a control experiment in which the measured passive flux was
õ3 nmol cmj2 hj1 when delivered from a 15 mM solution in
30 mM NaHCO3/133 mM NaCl (pH 7.4) into a receiver
containing 150 mM NaHCO3/133 mM NaCl (pH 7.4) for 5 h.
All experiments were replicated with n = 5 at least, using skin
sections from as many different animals as possible.
Iontophoresis Buffers
The buffers used were either (1) 30 mM NaHCO3/
133 mM NaCl, pH 7.4 (donor), 150 mM NaHCO3/133 mM
NaCl, pH 7.4 (receiver) for lysine, H-Lys-Lys-OH, H-His-
Lys-OH, and H-Glu-(-Lys-OH; or (2) phosphate-buffered
saline (PBS), pH 7.4 (16.8 mM Na2HPO4/1.4 mM KH2PO4/
136.9 mM NaCl) in all compartments, used with H-His-Lys-
OH, H-Glu-(-Lys-OH and tyrosine-containing dipeptides; or
(3) citrate buffer (10 mM citric acid/133 mM NaCl, pH 4.5)
for certain experiments with H-Tyr-His-OH and H-Tyr-Gln-
OH. Buffers were selected to minimize interference in the
peptide assay.
Dipeptides
Lysine- and tyrosine-containing dipeptides were studied,
as well as the cationic amino acid lysine (Table I). Ioniza-
tion states of the molecules are reported as discrete values
of charge (j1, 0, +1, +2) at pH 7.4 (for lysine and all the
dipeptides), and at pH 4.5 for H-Tyr-His-OH (i.e., a pH at
which histidine is almost completely positively charged (pKa
of His õ6Y6.5), rendering it more suitable for iontophoretic
delivery). Note that the ionization state of the dipeptides has
been estimated from the pKa values of the constituent amino
acids. However, the pKa values may differ slightly when these
amino acids are incorporated in dipeptides, because of a change
in their microenvironment (4,5). Charge/MW ratio was calcu-
lated by dividing the peptide valence by the molecular weight
(expressed in Da).
Theory
According to the NernstYPlanck theory, the total flux
(JTOT) of a molecule during iontophoresis is given by (6):
JTOT ¼ JP þ JEM þ JEO ð1Þ
where JP is the passive flux, and JEM and JEO are the con-
tributions of EM and EO, respectively. In this study, JTOT
and JEO were deduced from the receiver concentrations of
the amino acid/peptide and acetaminophen, respectively.
Because JP is negligible for the molecules delivered during
this study, JEM can be directly estimated from JTOT and JEO,
and the contribution of each transport mechanism can be
separated.
Table I. Dipeptides Physicochemical Properties
Amino acid/Dipeptide MW
Charge
(at pH 7.4)
Charge/MW
(10j3)
H-Lys-OH 146 +1 6.9
H-Lys-Lys-OH (KK) 274 +2 7.3
H-His-Lys-OH (HK) 283 +1 3.5
H-Glu-(-Lys-OH (E(K) 275 Zwitterion 0
H-Tyr-D-Arg-OH (YdR) 337 +1 3
H-Tyr-D-Arg-NH2 (YdR-NH2) 336 +2 6
H-Tyr-Lys-NH2 (YK-NH2) 308 +2 6.5
H-Tyr-His-OH (YH) 318 0a/+1b 0a/3.1b
H-Tyr-Phe-NH2 (YF-NH2) 327 +1 3.1
Ac-Tyr-Phe-OH (Ac-YF) 370 j1 j2.7
H-Tyr-Gln-OH (YQ) 309 Zwitterion 0
a Donor pH = 7.4.
b Donor pH = 4.5.
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The fraction of the total charge carried by an ionto-
phoretically delivered peptide is represented by its transport
number tPEP (2,7,8):
tPEP ¼ cPEP zPEP uPEPð Þ
.X
ciziuið Þ ð2Þ
where cPEP, zPEP, and uPEP represent the concentration,
valence, and mobility, respectively, of the peptide, and ci, zi,
and ui represent the corresponding values for the other
charge carriers in the system. The transport number is spe-
cific to each species under given conditions and is a measure
of the transport efficiency of a molecule. It can be deter-
mined from the steady-state flux using Faraday’s law
(2,6,8Y11):
JEM; PEP ¼ I tPEPð Þ= AF zPEPð Þ ð3Þ
where JEM, PEP is the electromigration flux of the peptide, I is
the applied current, F is Faraday’s constant, and A is the
contact area.
Combining Eqs. (1)Y(3) and introducing vAYC to rep-
resent the convective solvent flow from anode to cathode
(cm sj1) gives:
JTOT; PEP ¼ I
AF
uPEPP
ciziui
þ vA!C
 
cPEP ð4Þ
where JTOT, PEP represent the total flux of the peptide.
Analysis
Although all samples were assayed by reverse-phase
high-pressure liquid chromatography (RP-HPLC), the detec-
tion method depended on the nature of the dipeptide.
Lysine- and Lysine-Containing Dipeptides
As lysine does not possess a UV chromophore, an
alternative method was required for its detection after
chromatographic separation. Although the peptide bond in
the lysine-containing dipeptides, H-Lys-Lys-OH and H-His-
Lys-OH, has a UV absorbance at õ210 nm, cleavage of this
linkage during iontophoresis (see below), meant that transport
had to be estimated from the free lysine concentrations in the
receiver compartment.
We used precolumn derivatization with dimethylamino-
azobenzene sulfonyl chloride [dabsyl chloride (DABS Cl)] for
the detection of lysine and the three lysine-containing di-
peptides. Dabsylation involves a reaction between the amine
groups (of amino acids and peptides) and the sulfonyl chloride
group of DABS Cl to yield a sulfonamide derivative, which
has an absorbance maximum at l = 440 nm. Dabsylation con-
ditions in the literature (12Y16) were optimized with respect
to the ionic strength and type of buffer, DABS Cl concen-
tration and the solvent, heating temperature and duration,
and sample dilution.
The optimized procedure for lysine analysis was as
follows. In an Eppendorf tube (Treff\), 600 mL of a
solution of DABS Cl (7.5 mM in acetonitrile prepared just
before use) was mixed with 300 mL of a solution containing
lysine or the dipeptide in 150 mM NaHCO3 + 133 mM NaCl
solution (pH 7.4). The mixture was then heated in a water
bath (15 min at 70-C) and allowed to cool. The samples were
diluted using 600 mL of a 1:1 mixture of 50 mM phosphate
buffer pH 7 (prepared by adding 2 N NaOH to a solution of
50 mM phosphoric acid in water) and ethanol, and then
centrifuged (7000 rpm for 10 min). A portion (50 mL) of the
supernatant was injected into the HPLC system. These
samples were stable at room temperature for several weeks.
The HPLC system consisted of a 600E Controller pump, a
717-plus Autosampler Injector, an In-Line Degasser, and a
UV 2487 dual l Detector (Waters, Saint-Quentin Yvelines,
France). A C18 Nucleosil 120-3 column (L: 125 mm; ID:
4 mm; Macherey-Nagel, France) was used at ambient tem-
perature. The mobile phase, comprising 50 mM phosphate
buffer (pH 7)/acetonitrile (45:55), was delivered at a flow rate
of 1 mL minj1. As lysine has two amine groups, two peaks
were attributed to the amino acid, due to the mono- and
bisdabsylated lysine (as previously reported 14,16Y18). Only
the second peak (which eluted at õ7.6 min) was considered
because of its greater area and better separation. DABS Cl
also reacts with phenol moieties (19Y22), and dabsylation of
the phenol group of acetaminophen under the same condi-
tions (peak at õ9.2 min) enabled the simultaneous assay of
lysine and the EO marker. The limits of detection (LOD)
and quantification (LOQ) for lysine were 0.2 and 0.5 mM,
respectively; the relative standard deviation (RSD) of the
repeatability was <0.5% and the accuracy was within 2%.
During assay development, the choice of buffer in the
receiver phase (type and ionic strength) was found to affect
the quality of derivatization. For example, use of PBS gave
rise to parasite peaks that could not be separated from that of
lysine. For this reason, an extemporaneously prepared
bicarbonate buffer was employed [150 mM NaHCO3 +
133 mM NaCl solution (pH 7.4) in the receiver, and 30 mM
NaHCO3 + 133 mM NaCl solution (pH 7.4) in the electrode
compartments].
Tyrosine and Tyrosine-Containing Dipeptides
As tyrosine is a fluorescent amino acid (lex = 275 nm,
lem = 305 nm), its detection, as well as that of the tyrosine-
containing dipeptides, did not require derivatization. These
compounds were therefore quantified using the HPLC
system described above but with fluorescence detection
(Waters 474 Scanning Fluorescence Detector). The separa-
tion was performed on a C18 Nucleosil 100-5 Nautilus
column (L: 125 mm; ID: 4.6 mm; Macherey-Nagel) with a
98:2 mixture of 0.1% trifluoroacetic acid (TFA) in H2O (pH
2.5)/acetonitrile. The flow rate was 1 mL minj1, the
temperature was adjusted to 30-C, and 50 mL of sample were
injected. Tyrosine and acetaminophen eluted at õ5 and
13 min, respectively, although the latter was detected (in
the same run) by UV at 243 nm, again enabling a simulta-
neous analysis of the peptides and acetaminophen. The limits
of detection and quantification for tyrosine were 0.07 and
0.2 mM, respectively, with a coefficient of variation (CV) for
the precision of <1.7%; the CV for the accuracy was also
<1.7%. In the case of acetaminophen, the LOD and LOQ
were 0.2 and 0.8 mM, respectively, with a CV for the precision
of <2.9%; the corresponding CV for the accuracy was <0.9%.
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Tyrosine-containing dipeptides that also comprised the
unnatural amino acid, D-Arg, were resistant to metabolism
and could be assayed directly. For example, in the case of
H-Tyr-D-Arg-OH, the LOD and LOQ were 0.3 and 0.9 mM,
respectively; the CV for the precision and the accuracy were
<2.4% and <1.9%, respectively.
Data Treatment
All experiments were conducted with a minimum of five
replicates using skin from different pig ears. Statistical
analysis of the data was conducted either using Student’s
t test or analysis of variance. The level of statistical signifi-
cance was fixed at p < 0.05.
RESULTS AND DISCUSSION
Hydrolysis
Peptide hydrolysis was observed during iontophoresis of
H-Lys-Lys-OH, H-His-Lys-OH, H-Tyr-Lys-NH2, H-Tyr-His-
OH, H-Tyr-Phe-NH2, and H-Tyr-Gln-OH. During ionto-
phoretic transport across the skin, these dipeptides were
completely degraded into their constituent amino acids, which
were detected in the receiver phase and quantified. To identify
the site of this enzymatic activity, three experiments were
performed.
In the first, dermatomed skin was mounted in a vertical
diffusion cell and a solution of H-Lys-Lys-OH (200 mM in
150 mM NaHCO3/133 mM NaCl, pH 7.4) was placed in the
receiver compartment, as well as in the two electrode
compartments (20 mM in 30 mM NaHCO3/133 mM NaCl,
pH 7.4). After 4 h in the absence of current, analysis revealed
that although the peptide in the two electrode compartments
(in contact with the SC) had remained intact, only free lysine
was detected in the receiver compartment. This implied that
the peptide was stable in solution at room temperature, and
also when in contact with the outer layer of the skin, but was
completely degraded when in contact with the dermis,
perhaps as a result of the release of hydrolytic enzymes into
the receiver solution.
In the second experiment, H-Lys-Lys-OH (20 mM in
30 mM NaHCO3/133 mM NaCl) was iontophoresed across
porcine skin while samples were taken every 20 min to moni-
tor degradation kinetics. Only free lysine could be detected
in the receiver compartment, even after only 20 min of
current application. The dipeptide present in the donor
compartment remained intact, demonstrating that neither
current application nor electrode chemistry influenced pep-
tide stability.
In a third iontophoretic study, free lysine and H-His-
Lys-OH (10 mM in 30 mM NaHCO3/133 mM NaCl, pH 7.4)
were separately iontophoresed across porcine skin for 4 h. In
both cases, only free lysine was detected in the receiver
compartment at the end of the experiment; however, the
receiver levels of lysine subsequent to dipeptide iontophore-
sis were threefold lower than those after lysine iontophoresis.
The disparity between these levels of lysine in the two
experiments suggested that the permeating species in each
case was not the same. That is, in the case of H-His-Lys-OH,
the dipeptide had presumably been cleaved after passage (in
the intact form) across the SC, the rate-limiting barrier for
iontophoretic delivery. As H-His-Lys-OH has twice the
molecular weight but the same charge as lysine, it was
reasonable to assume that its transport would be less than
that of the free amino acid. Because hydrolysis occurred after
the rate-limiting step, it was possible to estimate dipeptide
transport from the free amino acid concentrations quantified
in the receiver compartment.
Every peptide that was subsequently used was first
tested for its susceptibility to enzymatic hydrolysis by placing
a 100 mM peptide solution in contact with the skin for 4 h
(in the absence of current) using the same buffer as that for
iontophoresis. The following dipeptides were completely
degraded when in contact with the dermis: H-Lys-Lys-OH,
H-His-Lys-OH, H-Tyr-Lys-NH2, H-Tyr-His-OH, H-Tyr-Phe-
NH2, H-Tyr-Gln-OH. Note that during the iontophoresis of
H-Tyr-Gln-OH in citrate buffer at pH 4.5, intact peptide
could be detected in the receiver, in addition to free tyro-
sine, suggesting a pH-dependent activity of the enzyme(s).
It is possible that the lower, nonphysiological pH reduced
enzyme catalytic efficiency. In those cases where partial
hydrolysis was observed, the total flux was calculated from
the sum of free amino acid and dipeptide present in the
receiver phase.
When benzamidine, a trypsin inhibitor, was added (in
excess) to the receiver phase, no reduction in catabolism was
observed, suggesting that trypsin-like skin enzymes were not
responsible for peptide hydrolysis. Other specific enzyme in-
hibitors were not investigated, because it was thought that
multiple enzymes were most probably involved in peptide
metabolism. It was hypothesized that the addition of a mix-
ture of different inhibitors would increase the number of com-
peting ions, thus reducing iontophoretic delivery efficiency,
and making definitive conclusions about the metabolic mech-
anisms impossible.
Peptides resistant to skin catabolism were also identi-
fied. The H-Glu-(-Lys-OH dipeptide, in which the peptide
bond involves the (-NH2 from the lysine side chain rather
than the a-NH2, was not cleaved by skin enzymes. Two
dipeptides that contained a D-amino acid, H-Tyr-D-Arg-OH
and H-Tyr-D-Arg-NH2, were also resistant to enzymatic
attack. Blocked peptides were stable only when the blocking
group was at the N-terminal end of the peptide. For example,
Ac-Tyr-Phe-OH was stable, whereas H-Tyr-Phe-NH2 was
degraded. These results suggested that the enzymes in
question were aminopeptidases, which have been previously
reported to be present in human and animal viable epidermis
(23Y27). This conclusion was further supported by experi-
ments investigating the stability of three other dipeptides:
Ac-Phe-Tyr-NH2, H-Tyr-Phe-OH, and Ac-Tyr-Phe-OMe.
Although Ac-Phe-Tyr-NH2 was stable, H-Tyr-Phe-OH was
metabolized. Ac-Tyr-Phe-OMe was peptidase-resistant (i.e.,
the peptide bond remained intact), but the methyl ester was
hydrolyzed, confirming significant esterase activity in the
skin. Furthermore, the tyrosine released after hydrolysis of
the tyrosine-containing dipeptides was subject to further
degradation, perhaps catalyzed by enzymes released from
the skin and present in the receiver phase. Hence for these
experiments, the receiver compartment was sampled manu-
ally and the solutions withdrawn were analyzed immediately
thereafter.
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Endogenous Amino Acid Release
The skin is rich in several amino acids including lysine
and tyrosine. These endogenous amino acids were released
into the receiver both passively and during iontophoresis;
release was most pronounced during the first and second
hours of current application. As described above, many of
the lysine- and tyrosine-containing dipeptides were subject to
considerable enzymatic hydrolysis during their transit across
the skin. Thus, control experiments, featuring the same con-
ditions as for dipeptide iontophoresis, but in the absence of
any peptide, were conducted to quantify the release of en-
dogenous amino acids (Fig. 1). This quantity of lysine or
tyrosine was then subtracted from the total amount of amino
acid found in the receiver after each dipeptide iontophoresis
experiment. Although endogenous lysine release was still
apparent after 5 h of current application (õ4 nmol cmj2 hj1),
this was not the case for tyrosine, which could not be
detected after 2 h.
Cationic Dipeptides
The iontophoretic fluxes of the cationic substrates
investigated in this study are reported in Fig. 2a, and
represent the total fluxes (JTOT) observed during iontopho-
resis at steady-state (SS), i.e., after 5 h of current application
in the case of lysine and lysine-containing dipeptides, and 7 h
for tyrosine-containing dipeptides. The fluxes reported for
H-His-Lys-OH and H-Tyr-His-OH were those obtained
with respective donor buffers of PBS (pH 7.4) and citrate/
133 mM NaCl (pH 4.5). Calculation of the acetaminophen
flux enabled separation of the EO and EM contributions to
peptide transport according to Eq. (1). The acetaminophen
flux was shown to be constant for all experiments with the
cationic dipeptides (57.4 T 12.8 nmol cmj2 hj1 at the end of
current application, n = 37, donor concentration = 15 mM);
that is, no inhibition of EO was induced by the dipeptides
studied; therefore, the differences in JTOT could be attributed
solely to variations in EM.
The molecules represented in Fig. 2a can be separated
into two groups: the first, with steady-state fluxes of
õ125 nmol cmj2 hj1, comprising H-His-Lys-OH, H-Tyr-D-
Arg-OH, H-Tyr-His-OH, and H-Tyr-Phe-NH2; the second
with steady-state fluxes of õ220 nmol cmj2 hj1 and comprising
lysine, H-Lys-Lys-OH, H-Tyr-Lys-NH2, and H-Tyr-D-Arg-
NH2. In addition to their similar delivery rates, molecules
within each group were also characterized by similar charge/
MW ratios (Table I). These results demonstrate that an in-
crease in charge can compensate for an increase in MW. For
example, a comparison of lysine and H-Lys-Lys-OH transport
reveals that the approximately twofold increase in molecular
weight (149 to 274 Da) was compensated by a doubling
of charge (JSS = 225 T 48 and 218 T 40 nmol cm
j2 hj1,
respectively); in contrast, H-His-Lys-OH, with approximately
the same molecular weight as H-Lys-Lys-OH but half the
charge, had a significantly lower flux (107 T 29 nmol cmj2 hj1).
For dipeptides of a given molecular weight, e.g., H-Tyr-D-Arg-
OH (MW = 337 Da, +1) and H-Tyr-D-Arg-NH2 (MW =
336 Da, +2), the increment in charge led to a significant dif-
ference in total flux. Moreover, none of the dipeptides
(or lysine) inhibited EO; the average EO contribution to
peptide transport, JEO, PEP, was 38.3 T 8.6 nmol cm
j2 hj1.
Hence, the difference in total flux was attributable entirely to
an increased EM contribution. In the case of lysine, H-Lys-
Lys-OH, and H-His-Lys-OH, JEM, PEP was estimated to be 187,
180, and 64 nmol cmj2 hj1, respectively. For H-Tyr-D-Arg-
OH and H-Tyr-D-Arg-NH2, JEM, PEP was estimated to be 108
Fig. 1. Release of endogenous lysine and tyrosine from the skin as a
function of time upon iontophoresis of buffer solution. The release of
lysine was determined using a 150 mM NaHCO3/133 mM NaCl (pH
7.4) receiver solution (30 mM NaHCO3/133 mM NaCl, pH 7.4, in the
upper compartments); tyrosine was measured with PBS (pH 7.4) in
all the compartments (n Q 5; mean T SD).
Fig. 2. (a) Steady-state iontophoretic fluxes (JSS) of lysine and
cationic dipeptides, where single-letter amino acid codes have been
used for clarity: F = Phe, H = His, K = Lys, R = Arg, Y = Tyr. The
respective contributions of electromigration (EM) and electroosmo-
sis (EO) are shown (n Q 5; mean T SD). (b) Transport numbers of
lysine and cationic dipeptides. Divalent molecules have approxi-
mately double the transport number of lysine, although their
iontophoretic fluxes are the same.
2073Effect of Charge and MW on Iontophoretic Peptide Delivery
and 199 nmol cmj2 hj1, respectively. As the EM contribution
is dependent on electrical mobility, this suggests that an
increase in peptide charge resulted in a corresponding
increase in mobility.
At first glance, these results may seem paradoxical. That
is, under constant current conditions, increased drug charge
should reduce iontophoretic delivery efficiency because fewer
molecules need to be transported to carry the same amount
of charge. Fundamentally, this assumes that the transport
number [Eq. (3)] remains constant and is not influenced by
the charge. However, this does not seem to be the case. For
example, a comparison of the transport data for lysine and
H-Lys-Lys-OH reveals that a twofold increase in charge is
paralleled by an equivalent increase in transport number
(Fig. 2), resulting in a similar flux (i.e., mass transport) when
iontophoresed under the same conditions. Figure 2b shows
two distinct groups of dipeptides; molecules within each group
are characterized by similar values of transport numbers,
ionization state, and charge/MW ratio: (1) H-His-Lys-OH,
H-Tyr-D-Arg-OH, H-Tyr-His-OH, and H-Tyr-Phe-NH2; and
(2) H-Lys-Lys-OH, H-Tyr-Lys-NH2 and H-Tyr-D-Arg-NH2.
Lysine has a lower transport number than the divalent di-
peptides because it only carries one positive charge.
Zwitterionic Dipeptides
The transport of two zwitterionic dipeptides (H-Tyr-
Gln-OH and H-Glu-(-Lys-OH), which contain both positive
and negative charge centers at physiological pH, was also
investigated. Zwitterions are often considered as neutral,
Bcharge-less^ molecules; if this was indeed the case, the
dipeptides would presumably be transported by EO alone,
and their permeation rate would be equivalent to that of
acetaminophen when delivered from the anode (using iden-
tical donor concentrations). However, experiments revealed
that their iontophoretic delivery, under various experimental
conditions, was far less than that expected. Indeed, no
transport of H-Glu-(-Lys-OH was observed after either
anodal (13 h) or cathodal (6 h) iontophoresis, when the
receptor was sampled uniquely at the end of the experiment.
For H-Tyr-Gln-OH, anodal delivery was no different from
passive transport (Table II). Although cathodal delivery of
H-Tyr-Gln-OH at pH 4.5 was higher than the passive control,
transport was still significantly less than that predicted from
the cathode-to-anode acetaminophen flux.
The results, particularly the negligible anodal delivery of
these dipeptides, suggest that the zwitterions are behaving
as (partially) negatively charged molecules at pH 7.4. To
understand their transport behavior, the relative extents of
dissociation of each ionizable group as a function of pH and
the resulting net charge on the molecule must be taken into
consideration (Fig. 3). At pH 7.4, the carboxylate and amine
groups of H-Tyr-Gln-OH [estimated isoelectric point (pI) =
5.64] are ionized at >99.99% and 98.09%, respectively (as-
suming pKa values are equal to those of the free amino
acids), and the molecule is partially negatively charged.
Despite this apparently small difference (1.9%), capillary
electrophoresis measurements confirmed its anionic char-
acter (Abla et al., personal communication). Moreover,
although these calculations can be made, to a first approxi-
mation, using the dissociation constants of the constituent
(free) amino acids, it is quite plausible that the latter do not
reflect the true pKa values of the dipeptides. Although it may
be argued that the hypothesized anionic nature of these
zwitterions is inconsistent with their insignificant cathodal
transport, it is possible that the EM flux was opposed, in this
case, by an EO flow of the same magnitude.
When H-Tyr-Gln-OH was delivered by cathodal ionto-
phoresis at pH 4.5 (in all compartments), transport was
higher relative to the passive control (Table II). Although
porcine skin is expected to be essentially uncharged and
nonpermselective at pH 4.5 on the basis of its reported pI of
4.4 (28), the cathodal delivery of acetaminophen in this study,
where the receptor was also buffered at pH 4.5, suggested the
Table II. Iontophoretic Delivery of the Zwitterion H-Tyr-Gln-OH Under Different Experimental Conditions
Donor compartment
pHa
Steady-state flux
(nmol cmj2 hj1)
Anode Cathode Receiver Peptide Acetaminophenb
Anode 7.4 7.4 7.4 5.4 T 4.3 66.1 T 3.7
Anode 4.5 7.4 7.4 7.3 T 3.8 55.2 T 12.7
Cathode 7.4 7.4 7.4 4.9 T 0.6 Y
Cathode 4.5 4.5 4.5 21.9 T 10.1 j76.9 T 28.0
Control (passive) 7.4 Y 7.4 4.9 T 0.6
a Solutions at pH 7.4 contained PBS, while solutions at pH 4.5 were buffered with citrate +133 mM NaCl.
b Negative value indicates solvent flow in cathode-to-anode direction.
Fig. 3. Ionization profile of H-Tyr-Gln-OH calculated using the pKa
values of the amine and carboxylic acid groups in free tyrosine
and glutamine, respectively. At pH 4.5, the carboxylic acid group is
99% ionized.
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presence of considerable EO in the cathode-to-anode direc-
tion. Nevertheless, the total flux of H-Tyr-Gln-OH remained
lower than that of acetaminophen because the dipeptide was
now partially positively charged (formulation pH < pI of H-
Tyr-Gln-OH) and not conducive to cathodal iontophoresis.
Therefore, it is apparent that zwitterionic peptides are
complex candidates for iontophoresis and that their success-
ful delivery requires judicious formulation. Studies should
include accurate measurement of the dipeptide dissociation
constants, which, as discussed above, may differ from those of
the constituent amino acids. Formulation at a pH equal to the
pI of the zwitterions, such that its net charge is zero (i.e., it
effectively behaves as a neutral Bcharge-less^ molecule), may
facilitate electroosmotic transport from the anodal compart-
ment. However, as the pH across the skin progressively
increases (from õ5 at the surface to 7.4 in the viable layers),
the zwitterion’s ionization state may change as a function of
its local microenvironment. Hence, a molecule with zero net
charge in the anodal (donor) compartment may attain a net
partial negative charge in the skin, at which point the EO
driving force would be opposed by EM back toward the
anode. Although blocking the N and C termini of zwitter-
ionic peptides to Bneutralize^ these molecules for more
efficient EO transport is also feasible, Ac-Phe-Tyr-NH2
could not be delivered because of the very poor solubility
of this blocked peptide in PBS (pH 7.4).
Effect of Donor pH: H-Tyr-His-OH
Iontophoretic delivery of H-Tyr-His-OH was studied from
formulations at pH 4.5 (citrate buffer/133 mM NaCl) and pH
7.4 (PBS) (Fig. 4); in both cases, the receiver compartment was
maintained at pH 7.4. The acetaminophen flux, and hence the
contribution of EO to dipeptide transport, was the same ir-
respective of donor pHVsuggesting that the pH of the solution
bathing the dermal layer controlled skin pH. Given that the
pKa of free histidine is õ6Y6.5, it is only weakly cationic at pH
7.4, but fully protonated at pH 4.5. The increased cationic
character of H-Tyr-His-OH at pH 4.5, and consequent
increase in electrical mobility, was manifest by a greater EM
flux: JEM, PEP (89.2 nmol cm
j2 hj1 at pH 4.5 vs. 46.2 nmol
cmj2 hj1 at pH 7.4). However, when the dermal compartment
was buffered at pH 4.5, a value close to the skin pI, the
concomitant change in skin permselectivity was translated
into a reversal of EO flow in the cathode-to-anode direc-
tion. Under these conditions, the measured dipeptide flux
(JTOT, PEP) results from two opposing forces (EM from anode-
to-cathode and EO from cathode-to-anode), and Eq. (4)
becomes:
JTOT; PEP ¼ I
AF
uPEPP
ciziui
 vC!A
 
cPEP
¼ JEM; PEP  JEO; PEP ð5Þ
For comparison, note that the cathodal delivery of this dipep-
tide using PBS pH 7.4 in all compartments was negligible
(4.8 T 1.7 nmol cmj2 hj1). In summary, the skin pH was
determined by the milieu in contact with the dermal phase;
thus, although formulation pH can be modified to optimize
drug ionization and solubility, it might not be able to change
skin permselectivity.
Effect of Donor Buffer Composition: H-His-Lys-OH
As shown earlier (Fig. 2a), the iontophoretic flux of H-
His-Lys-OH from a donor comprising PBS (pH 7.4) into a
receiver compartment with 150 mM NaHCO3/133 mM NaCl
(pH 7.4) was 106.9 T 29.3 nmol cmj2 hj1 after 5 h. This
equates to approximately 50% of the lysine and H-Lys-Lys-
OH transport rates, and is reasonably consistent with the
value predicted from its charge/MW ratio. However, when
the donor formulation was changed to 30 mM NaHCO3/
133 mM NaCl (pH 7.4), the steady-state flux was approxi-
mately halved (59.1 T 9.7 nmol cmj2 hj1). Therefore, the
bicarbonate-containing formulation seemed to decrease the
peptide delivery efficiency, despite having an equivalent
concentration of competing cations (õ170 mM Na+) and
lower overall ionic strength (0.163 cf. 0.246 mol lj1). It is also
worth noting that, whereas histidine seemed to be in part
positively charged in H-Tyr-His-OH at pH 7.4 (JTOT, PEP
at pH 7.4 > JEO, PEP), it seemed to be uncharged in H-His-
Lys-OH at the same pH. The pKa of histidine is reported to
Fig. 4. Contributions of electromigration (EM) and electroosmosis
(EO) to the steady-state iontophoretic flux (JSS) of H-Tyr-His-OH
delivered from the anodal compartment as a function of pH in the
donor (D) and receiver (R) compartments; the fluxes were signifi-
cantly different (ANOVA, p < 0.05) (n Q 5; mean T SD).
Fig. 5. EM flux of anionic Ac-Tyr-Phe-OH and cationic H-Tyr-Phe-
NH2 (n Q 5; mean T SD).
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vary as a function of the environment, and is influenced by
the nature of the neighboring amino acids and the ionic
strength of the medium (29,30). Therefore, it is possible that
the substitution of lysine by tyrosine and, more importantly
perhaps, the location of the imidazole group in H-Tyr-His-
OH at the C-terminal, and close to the electron-rich
carboxylate group, modifies the acidity of the proton and,
hence, the degree of ionization.
Anionic Dipeptide: Ac-Tyr-Phe-OH
Ac-Tyr-Phe-OH has the same amino acid sequence as
H-Tyr-Phe-NH2; but whereas the former is acetylated at the
N-terminal, the latter is blocked at the C-terminal by
amidation; thus H-Tyr-Phe-NH2 is positively charged where-
as Ac-Tyr-Phe-OH carries a negative charge at physiological
pH. These peptides were used, therefore, to investigate
whether the EM contribution to their electrotransport was
the same. Electromigration of the anion was determined using
Eq. (5), assuming that cathodal delivery was opposed by EO.
Comparison of JEM YFNH2ð Þ and JEM(Ac-YF) (Fig. 5) shows
that the time taken to reach steady state was greater for
the negatively charged Ac-Tyr-Phe-OH, with the result that
JEM YFNH2ð Þ was more than twofold greater than JEM(Ac-YF)
after 1 h of iontophoresis. However, the EM fluxes at steady-
state were similar for the two dipeptides. Further analysis
suggested that the discrepancy between H-Tyr-Phe-NH2 and
Ac-Tyr-Phe-OH was attributable to the former attaining
steady state more quickly (õ2 h) than the other cationic
dipeptides studied which, in agreement with Ac-Tyr-Phe-OH,
also took õ4 h.
Relationship Between Charge/MW Ratio and Flux
The EM fluxes of the molecules studied were linearly
correlated to their charge/MW ratio (Fig. 6). To include the
zwitterions, H-Tyr-Gln-OH and H-Glu-(-Lys-OH, in this
analysis, they were attributed an arbitrary charge of j0.5
based on their transport data and ionic mobilities (Abla et al.,
personal communication). Moreover, as their total cathodal
iontophoretic flux, JTOT, at pH 7.4, was negligible, it can be
argued that Bcathode-to-anode^ EM must be approximately
equal to the anode-to-cathode solvent flow. Therefore, the
mean value of JEO observed with the cationic dipeptides
(approximately j38 nmol cmj2 hj1) was used to estimate
JEM for the zwitterions; this JEM was considered to be
negative because it describes transport from cathode to
anode. As none of the molecules studied here interacted
with the membrane and the electroosmotic contribution
(JEO) was effectively constant, the observed differences in
transport were due exclusively to variations in the electro-
migratory component (JEM). In addition to the dipeptides
studied here, transport data for lidocaine, propranolol, and
quinine are included in Fig. 6 (31). These molecules have
similar molecular weights to the amino acids/peptides studied
here and, as Fig. 6 shows, their iontophoretic fluxes are in
good agreement with the current data despite differences in
the composition of the donor electrode formulation.
CONCLUSIONS
The results presented here demonstrate that for the
amino acids and dipeptides studied, iontophoretic flux was
strongly governed by the charge/MW ratio and not, exclusive-
ly, by either parameter in isolation. That is, with respect to
EM, an increase in molecular weight was compensated by a
corresponding increase in charge. Moreover, at a given
molecular weight, increasing peptide charge enhanced EM
flux. These findings have implications for the selection of drug
candidates for iontophoresis and for the evaluation of the
relative merits of structurally related compounds. For exam-
ple, monovalent cations should not be taken as de facto
superior candidates to di- and trivalent molecules, because
the higher charge/MW ratios of the latter may render them
more mobile (assuming that they do not increase propensity
to interact with the membrane). The presence of multiple
charge centers in higher valence ions could considerably
modify their transport number compared to the univalent
species.
What do these results teach us about the molecular
weight limit for drugs that can be delivered by iontophoresis?
We have shown that compensation of molecular weight by
charge certainly holds for relatively low molecular com-
pounds (MW õ 300 Da); ionic mobility decreases with
increasing molecular weight and although increasing charge
can offset this to some extent, this may be insufficient above
a given molecular weight. Furthermore, the probability of
interaction with the transport pathway will also increase with
increasing molecular weight (and hence molecular volume)
and this would obviously hinder delivery. The literature
shows that calcitonin, human parathyroid hormone, and
growth hormone releasing factor analogsVmonovalent pep-
tides with molecular weights in the 3.5- to 5-kDa rangeVcan
be delivered without additional barrier impairment (32Y39).
Published investigations on the transport of higher molecular
weight, multiply charged species are rare, although the
delivery of cytochrome c (MW = 12.4 kDa, multiple charges)
across excised human skin has been reported (40,41). Further
studies are obviously required to address this issue more
completely. However, it must be remembered that, as
Fig. 6. Correlation between the EM flux of lysine and all dipeptides
studied in this work (full circles), and quinine, propranolol, and
lidocaine from [31] (open circles), and their corresponding charge/
MW ratio. For dipeptides: EM flux = 27.02{charge/MW 10j3}, r2 =
0.96. When adding the nonpeptidic drugs: EM flux = 28.99{charge/
MW}, r2 = 0.91.
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peptides and proteins increase in size, they are more likely to
have tertiary and quaternary structure that is essential for
pharmacological effect; the delivery conditions must there-
fore ensure that biological activity is maintained.
The transport data for the histidine-containing dipep-
tides indicate the influence of neighboring amino acids and
the local microenvironment on the acidity of the imidazole
group; this may have implications for the delivery of peptides
containing charged residues for which selection of the
formulation pH might be critical to achieve the desired
ionization state of the molecule. On a related note, the
different transport rates of H-His-Lys-OH observed from
formulations at the same pH but using different buffering
systems also serve to highlight that interactions with the
buffer may further complicate formulation design. Similarly,
the work on zwitterion transport has shown that these
molecules should not be regarded as neutral species per se
and that the individual pKa values of the ionizable groups of
the component amino acids, as well as the effect of the local
environment, should be considered in the determination of
the net charge.
Finally, although catabolic enzymatic activity in the skin
is considerably less than that in the gastrointestinal tract and
liver, an enzymatic barrier to transdermal delivery is evident.
Enzymatic hydrolysis seemed to occur after passage through
the stratum corneum, the rate-limiting barrier to transport. It
was also observed that amide bonds containing (-NH2 groups
from the lysine side chain were more resistant to hydrolysis
than peptide linkages with the a-NH2 group. Furthermore,
dipeptides containing D-amino acids, and those with blocked
N-termini, were also less susceptible to enzymatic attack. The
results using selectively blocked dipeptides point to the in-
volvement of aminopeptidases during passage across the skin.
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